They boost insulin secretion during meals, which can lower blood glucose spikes after eating
Activating both receptors can mitigate the undesirable effects of glucagon and improve obesity and metabolic complications [106]
With over 500,000 people in the UK now using GLP-1 medications and that number growing as oral formulations become more widely available this is a concern affecting tens of thousands of women

Disclosures: Phuc Le: Nothing to Disclose, William Herman: Merck Sharp & Dohme: Advisor, Rivus Pharmaceuticals: Advisor, Srinivasan Dasarathy: Nothing to Disclose, Wen Ye: Nothing to Disclose, Victoria Criswell: Nothing to Disclose, Nicole Welch: Nothing to Disclose, Michael Rothberg: Moderna: Stock - publicly traded company 1763 CLINICAL OUTCOMES OF UTILIZING AN INTERACTIVE CARE PLAN (ICP) IN PATIENTS WITH CIRRHOSIS Kathryn Schmidt 1 Jessica Grimm 1 Devin Copley 1 Daniel Penrice 1 Barbara Copeland 1 William Harmsen 1 Rachel Gullerud 1 Winnie Fan 1 Jordan Coffey 1 Julianne Lunde 1 Sarah Harper 1 Hugo Vargas 2 Blanca Lizaola-Mayo 2 Douglas Simonetto 1 , 1 Mayo Clinic Rochester, 2 Mayo Clinic Arizona Background: Patients with cirrhosis face an increased risk of disease-related symptoms and complications, leading to reduced quality of life
After 2 weeks recovery from pump placement, mice were randomized to voluntary wheel running (VWR) or usual activity (UA) for 4 weeks